FAST Mapping During Atrial Fibrillation

Sponsor
University Health Network, Toronto (Other)
Overall Status
Completed
CT.gov ID
NCT02271152
Collaborator
(none)
80
1
2
48
1.7

Study Details

Study Description

Brief Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with a prevalence of 8% in the elderly. AF is responsible for frequent hospitalizations, stroke, heart failure and mortality. AF catheter ablation is an important treatment strategy for patients suffering from AF, but the success rate remains low after conventional pulmonary vein isolation (PVI). The mechanism perpetuating AF is poorly understood. Focal electrical sources and triggers (FAST) may sustain AF in some patients, which makes them a potential therapeutic target for ablation. However, finding FAST is very challenging due to complex nature of AF electrical signals. In this study, the investigators will attempt to localize focal electrical sources and triggers (FAST mapping) in patients undergoing AF ablation using custom software that evaluates periodicity and waveform morphology. Patients will be randomized to one of two AF ablation strategies, namely FAST mapping/ablation + PVI vs. PVI alone. The investigators will determine which strategy leads to better clinical outcome postablation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: FAST mapping and ablation
  • Procedure: PVI
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Focal Electrical Source and Trigger Mapping During Atrial Fibrillation
Actual Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Feb 1, 2019
Actual Study Completion Date :
Feb 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: FAST ablation + PVI

FAST mapping and ablation will be performed in addition to PVI

Procedure: FAST mapping and ablation

Procedure: PVI

Active Comparator: PVI

Pulnonary vein isolation will be performed

Procedure: PVI

Outcome Measures

Primary Outcome Measures

  1. Time to first symptomatic atrial fibrillation recurrence postablation [3 months postablation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • All patients must be over the age 18 and have a clinical indication for their first catheter ablation of AF because of symptomatic AF.

  • This will include patients with either high burden paroxysmal (>4 self-terminating episodes of AF within the last 6 months with two episodes lasting at least 6 hours within the last year) or persistent AF (lasting ≥7 days, but which can still be converted to sinus rhythm).

Exclusion Criteria:
  • The major exclusion criteria will include:

  • long-standing persistent AF (ie. AF which cannot be converted to sinus rhythm, or where multiple attempts at restoring sinus rhythm have failed)

  • rheumatic valvular disease

  • hypertrophic cardiomyopathy

  • uncorrected cardiac shunts (eg. secundum ASD)

  • severe mitral regurgitation or mechanical mitral valve

  • left atrial size >55 mm (echo derived parasternal long axis view).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Health Network Toronto Ontario Canada M5G 2C4

Sponsors and Collaborators

  • University Health Network, Toronto

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Vijay Chauhan, Cardiologist, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT02271152
Other Study ID Numbers:
  • 2013-121
First Posted:
Oct 22, 2014
Last Update Posted:
Mar 6, 2019
Last Verified:
Mar 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2019